Alprazolam, when added under double-blind conditions to a stable neuroleptic regimen in two patients with schizophrenia, resulted in clinically apparent improvement in positive and negative schizophrenic symptoms. Both patients showed significant worsening of symptoms following reduction of discontinuation of alprazolam.
|Original language||English (US)|
|Number of pages||3|
|Journal||American Journal of Psychiatry|
|State||Published - 1986|
ASJC Scopus subject areas
- Psychiatry and Mental health